Senate Concurrent Resolution No. 41–Senators Porter, Amodei, Care, Carlton, Coffin, Jacobsen, James, Mathews, McGinness, Neal, O’Connell, O’Donnell, Raggio, Rawson, Rhoads, Schneider, Shaffer, Titus, Townsend, Washington and Wiener
Joint Sponsors: Assemblymen Brown, Anderson, Angle, Arberry, Bache, Beers, Berman, Brower, Buckley, Carpenter, Cegavske, Chowning, Claborn, Collins, de Braga, Dini, Freeman, Gibbons, Giunchigliani, Goldwater, Gustavson, Hettrick, Humke, Koivisto, Lee, Leslie, Manendo, Marvel, McClain, Mortenson, Neighbors, Nolan, Oceguera, Ohrenschall, Parks, Parnell, Perkins, Price, Smith, Tiffany, Von Tobel and Williams
Senate Concurrent RESOLUTION—Recognizing May 9, 2001, as Alzheimer’s Disease Awareness Day.
Whereas, Alzheimer’s disease is a progressive, degenerative brain
disorder characterized by memory loss, language deterioration, poor
judgment and indifferent attitude, but preserved motor function; and
Whereas, Approximately 4 million Americans now suffer from
Alzheimer’s disease, including approximately 1 in every 10 persons over
65 years of age and nearly half of those persons over 85 years of age; and
Whereas, At the current rate of incidence, it is estimated that 14
million Americans will be afflicted with Alzheimer’s disease by the middle
of this century; and
Whereas, A person with Alzheimer’s disease will live an average of 8
years and may live as long as 20 years or more after the onset of
symptoms; and
Whereas, More than 7 out of 10 persons with Alzheimer’s disease live
at home, with care being provided by family and friends; and
Whereas, At some point, an Alzheimer’s victim will require 24-hour
care, including assistance with such daily activities as eating, grooming and
toileting; and
Whereas, It has been estimated that expenses for the diagnosis, care
and treatment of Americans with Alzheimer’s disease amount to at least
$100 billion each year; and
Whereas, Much of the amount necessary for the care and treatment of
Alzheimer’s patients is not compensated by Medicare, including the cost of
most prescription drugs and long-term care; and
Whereas, Alzheimer’s disease is the third most expensive illness in the
United States, behind only heart disease and cancer; and
Whereas, Statistics show that if scientists can delay the onset of
Alzheimer’s disease by just 5 years, the number of persons contracting the
disease can be reduced by half, thus saving this country billions of dollars
in healthcare costs; and
Whereas, While a cure for Alzheimer’s disease has yet to be found, the
Food and Drug Administration just recently approved a new drug for the
treatment of mild to moderate cases of this disease, with the brand name
Reminyl, which helps to improve the cognitive performance and daily
functioning of patients; and
Whereas, The Alzheimer’s Association, through its national network
of more than 200 chapters, provides support to patients, families and
caregivers, educates both the general public and health professionals about
Alzheimer’s disease and related disorders, and supports research endeavors
with the hope of finding a cure; and
Whereas, The Northern Nevada Chapter and Southern Nevada Chapter
of the Alzheimer’s Association provide support to an estimated 35,000
persons with Alzheimer’s disease in this state; now, therefore, be it
Resolved by the Senate of the State of Nevada, the Assembly
Concurring, That the Nevada Legislature is committed to creating a
greater public understanding of Alzheimer’s disease and to supporting the
need for continued research; and be it further
Resolved, That May 9, 2001, is hereby recognized as Alzheimer’s
Disease Awareness Day.
20~~~~~01